Biogen Inc (BIIB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,186,281 | 863,197 | 828,601 | 602,562 | 427,811 |
| Marketable Securities | 675,065 | 709,869 | 431,610 | 620,167 | 240,882 |
| Receivables | 1,091,232 | 1,002,328 | 1,018,487 | 824,406 | 891,396 |
| Inventories | 753,063 | 715,935 | 672,750 | 659,003 | 614,483 |
| Other current assets | 666,470 | 633,684 | 573,576 | 478,796 | 469,100 |
| TOTAL | $4,372,111 | $3,925,013 | $3,525,024 | $3,184,934 | $2,643,672 |
| Non-Current Assets | |||||
| PPE Net | 1,724,129 | 1,756,164 | 1,744,266 | 1,750,710 | 1,806,074 |
| Investments And Advances | 1,936,944 | 1,622,628 | 1,363,541 | 1,220,122 | 1,009,586 |
| Intangibles | 5,670,958 | 5,614,193 | 5,597,300 | 5,707,569 | 5,790,917 |
| Other Non-Current Assets | 0 | -1 | 0 | -1 | 0 |
| TOTAL | $9,332,031 | $8,992,984 | $8,705,107 | $8,678,400 | $8,606,577 |
| Total Assets | $13,704,140 | $12,918,000 | $12,230,130 | $11,863,330 | $11,250,250 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 233,629 | 224,931 | 212,809 | 219,913 | 166,709 |
| Accrued Expenses | 1,544,160 | 1,495,549 | 1,216,843 | 1,355,187 | 1,204,437 |
| TOTAL | $1,940,647 | $1,916,624 | $1,594,247 | $1,758,279 | $1,518,711 |
| Non-Current Liabilities | |||||
| Long Term Debt | 583,977 | 586,091 | 591,012 | 592,433 | 694,894 |
| aiOther Non-Current Liabilities | 659,014 | 702,339 | 703,136 | 659,231 | 608,473 |
| TOTAL | $1,332,610 | $1,436,148 | $1,494,821 | $1,484,218 | $1,605,850 |
| Total Liabilities | $3,273,257 | $3,352,772 | $3,089,068 | $3,242,497 | $3,124,561 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 236,155 | 236,145 | 237,200 | 236,000 | 236,213 |
| Common Shares | 129 | 128 | 128 | 128 | 128 |
| Retained earnings | 8,400,455 | 7,543,597 | 6,829,091 | 6,349,135 | -29,315 |
| Other shareholders' equity | -34,711 | -22,583 | -17,930 | -27,076 | 5,892,498 |
| TOTAL | $10,430,880 | $9,565,226 | $9,141,063 | $8,620,838 | $8,125,688 |
| Total Liabilities And Equity | $13,704,137 | $12,917,998 | $12,230,131 | $11,863,335 | $11,250,249 |